MRV — Marvell Technology, Inc. | ScreenerHero

Create free account Sign in

MRVMarvell Technology, Inc.

TSX · CA · Healthcare · Drug Manufacturers - General

43.00CAD-16.92%Mkt Cap: 37.65B CADP/E: 10.67Last update: 2026-06-05

Industry Peers

Drug Manufacturers - General

AstraZeneca PLC

2.70TSEKP/E 27.9

Novo Nordisk A/S

1.26TDKKP/E 10.4

Eli Lilly and Company

1.01TUSDP/E 40.2

Johnson & Johnson

560.33BUSDP/E 27.0

401.47BUSDP/E 110.8

Merck & Co., Inc.

298.33BUSDP/E 34.0

Roche Holding AG

264.30BCHFP/E 20.7

229.10BCHFP/E 20.9

Indicators:|

Key Statistics

Company

Market Cap37.65B CAD

Enterprise Value—

Revenue (TTM)—

Gross Profit4.18B CAD

Net Income (TTM)2.67B CAD

Revenue/Share—

Last Price43.00 CAD

Fiscal Year End—

MR Quarter—

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - General

ISIN—

Valuation

P/E (Trailing)10.67

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B1.49

EPS (TTM)—

EPS (Forward)—

52W Range

26.0063% of range52.87

52W High52.87 CAD

52W Low26.00 CAD

Profitability

Gross Margin51.02%

Oper. Margin—

EBITDA Margin—

Profit Margin32.58%

ROE18.66%

ROA11.98%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF1.75B CAD

CapEx (TTM)358.60M CAD

FCF Margin—

FCF Yield—

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.33

Current Ratio—

Quick Ratio—

Book Value/Sh28.91 CAD

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.2400 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.875.55M

Float—

Insiders—

Institutions—

Technical

SMA 5032.59 (+31.9%)

SMA 20032.59 (+31.9%)

Beta—

S&P 52W Chg—

Avg Vol (30d)72.21K

Avg Vol (10d)93.22K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—